Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Zilli T, Franzese C, Bottero M, Giaj-Levra N, Forster R, Zwahlen D, Koutsouvelis N, Bertaut A, Blanc J, D'agostino GRoberto, Alongi F, Guckenberger M, Scorsetti M, Miralbell R |
| Journal | RADIOTHERAPY AND ONCOLOGY |
| Volume | 139 |
| Pagination | 83-86 |
| Date Published | OCT |
| Type of Article | Article; Proceedings Paper |
| ISSN | 0167-8140 |
| Mots-clés | monotherapy, Phase I/II trial, Prostate cancer, SBRT, Toxicity |
| Résumé | The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking. (C) 2019 Elsevier B.V. All rights reserved. |
| DOI | 10.1016/j.radonc.2019.07.018 |